These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 6822725
1. A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection. Goodeve A, Potter CW, Clark A, Jennings R, Schild GC, Yetts R. J Hyg (Lond); 1983 Feb; 90(1):107-15. PubMed ID: 6822725 [Abstract] [Full Text] [Related]
2. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity. Clark A, Potter CW, Jennings R, Nicholl JP, Langrick AF, Schild GC, Wood JM, Tyrrell DA. J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910 [Abstract] [Full Text] [Related]
3. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection. Masurel N, Laufer J. J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638 [Abstract] [Full Text] [Related]
4. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity. Clark A, Potter CW, Jennings R, Nicholl JP, Langrick AF, Schild GC, Wood JM, Tyrrell DA. J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909 [Abstract] [Full Text] [Related]
5. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines. Potter CW, Jennings R, Nicholson K, Tyrrell DA, Dickinson KG. J Hyg (Lond); 1977 Dec; 79(3):321-32. PubMed ID: 270523 [Abstract] [Full Text] [Related]
6. Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature. Palache AM, Beyer WE, Lüchters G, Völker R, Sprenger MJ, Masurel N. Vaccine; 1993 Dec; 11(9):892-908. PubMed ID: 8212834 [Abstract] [Full Text] [Related]
7. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J. Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689 [Abstract] [Full Text] [Related]
8. A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group. Potter CW, Jennings R, McLaren C, Edey D, Stuart-Harris CH, Brady M. J Hyg (Lond); 1975 Dec 25; 75(3):353-62. PubMed ID: 1059705 [Abstract] [Full Text] [Related]
9. Assessment of resistance to influenza virus infection in animal models. Potter CW, McLaren C, Jennings R. Dev Biol Stand; 1975 Dec 25; 28():307-18. PubMed ID: 1126574 [Abstract] [Full Text] [Related]
10. Comparative trials of live attenuated and detergent split influenza virus vaccines. Mackenzie JS, Mackenzie I, Lloyd J, Dent V. J Hyg (Lond); 1975 Dec 25; 75(3):425-43. PubMed ID: 1059709 [Abstract] [Full Text] [Related]
11. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1). Schmidt S, Süss J, Oehring H, Schmidt J. Acta Virol; 1982 Dec 25; 26(6):466-73. PubMed ID: 6132540 [Abstract] [Full Text] [Related]
12. Immunity to challenge in volunteers vaccinated with an inactivated current or earlier strain of influenza A(H3N2). Larson HE, Tyrrell DA, Bowker CH, Potter CW, Schild GC. J Hyg (Lond); 1978 Apr 25; 80(2):243-8. PubMed ID: 632564 [Abstract] [Full Text] [Related]
13. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. Hobson D, Curry RL, Beare AS, Ward-Gardner A. J Hyg (Lond); 1972 Dec 25; 70(4):767-77. PubMed ID: 4509641 [Abstract] [Full Text] [Related]
14. Studies with inactivated equine influenza vaccine. 1. Serological responses of ponies to graded doses of vaccine. Wood JM, Mumford J, Folkers C, Scott AM, Schild GC. J Hyg (Lond); 1983 Jun 25; 90(3):371-84. PubMed ID: 6345659 [Abstract] [Full Text] [Related]
15. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine. Potter CW, Jennings R, Phair JP, Clarke A, Stuart-Harris CH. J Infect Dis; 1977 Mar 25; 135(3):423-31. PubMed ID: 850080 [Abstract] [Full Text] [Related]
16. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection. Monto AS, Petrie JG, Cross RT, Johnson E, Liu M, Zhong W, Levine M, Katz JM, Ohmit SE. J Infect Dis; 2015 Oct 15; 212(8):1191-9. PubMed ID: 25858957 [Abstract] [Full Text] [Related]
17. Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin. Hashigucci K, Ogawa H, Ishidate T, Yamashita R, Kamiya H, Watanabe K, Hattori N, Sato T, Suzuki Y, Nagamine T, Aizawa C, Tamura S, Kurata T, Oya A. Vaccine; 1996 Feb 15; 14(2):113-9. PubMed ID: 8852406 [Abstract] [Full Text] [Related]
18. Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers. Yamane N, Nakamura Y, Yuki M, Odagiri T, Ishida N. J Hyg (Lond); 1984 Apr 15; 92(2):231-42. PubMed ID: 6707472 [Abstract] [Full Text] [Related]
19. Hemagglutinin-specific CD4+ T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humans. Tan S, Zhang S, Wu B, Zhao Y, Zhang W, Han M, Wu Y, Shi G, Liu Y, Yan J, Wu G, Wang H, Gao GF, Zhu F, Liu WJ. Vaccine; 2017 Oct 09; 35(42):5644-5652. PubMed ID: 28917539 [Abstract] [Full Text] [Related]
20. Reactogenicity and immunogenicity of a surface-antigen-adsorbed influenza virus vaccine in children. Eastwood LM, Jennings R, Milner RD, Potter CW. J Clin Pathol; 1979 Jun 09; 32(6):534-7. PubMed ID: 469010 [Abstract] [Full Text] [Related] Page: [Next] [New Search]